Metal complexes of silver(I), nickel(II) and copper(II) with the mixed
ligands of acesulfame (ace) and triphenylphosphine (PPh3) were prepared
in this work. The complexes of [Ag(ace)]n (1), [Ag(ace)(PPh3)] (2),
[Ni(ace)2(H2O)4] (3),[Ni(ace)2(PPh3)2] (4), [Cu(ace)2(H2O)2] (5) and
[Cu(ace)2(PPh3)2] (6) were characterised by FT-IR and NMR spectroscopy,
Mass spectrometry including X-Ray powder diffraction. The synthesised
complexes were examined in their anticancer activity against A549 lung
cancer cells which were further evaluated their efficiency by IC50 method.
[Ag(ace)]n (1), [Ni(ace)2(H2O)4] (3) and [Cu(ace)2(H2O)2] (5) which contain
only acesulfame ligand exhibited higher IC50 values in comparison to
the mixed ligands of ace and PPh3. [Ag(ace)(PPh3)] (2), [Ni(ace)2(PPh3)2] (4)
and [Cu(ace)2(PPh3)2] (6) displayed the inhibition in the growth of cancer cells
with IC50 values of 1.65, 13.45 and 1.06 μM, respectively. Additionally,
silver(I) and copper(II) complexes also presented better activity than
the standard Etoposide (IC50 5.623 μM). The results indicated that
the mixed ligands could perform more excellent inhibition of cancer cells
growing in comparison to the using of only acesulfame or triphenylphosphine
ligand.